Aethlon Medical (AEMD) Return on Capital Employed (2011 - 2026)
Aethlon Medical (AEMD) posted Return on Capital Employed of 126.88% for Q1 2026, down 10.78% on a QoQ basis from 114.54% in Q4 2025, and up 5835.0% year-over-year from 2.14% in Q1 2025.
Aethlon Medical (AEMD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Aethlon Medical's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 126.88% for Q1 2026.
- Quarterly Return on Capital Employed rose 5835.0% year-over-year to 126.88% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 126.88% (up 5835.0% YoY) and the FY2026 annual result came in at 135.08%, up 2315.0% from the prior year.
- Return on Capital Employed was 126.88% for Q1 2026 at Aethlon Medical, down from 114.54% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 55.3% in Q1 2022 and bottomed at 185.23% in Q1 2025.
- A 5-year average of 119.4% and a median of 126.88% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed plunged 10067 bps — and 2026, when it jumped 5835 bps.
- Aethlon Medical's Return on Capital Employed stood at 67.9% in 2022, then plunged by 95 bps to 132.49% in 2023, then slipped by 25 bps to 166.15% in 2024, then soared by 31 bps to 114.54% in 2025, then dropped by 11 bps to 126.88% in 2026.
- Business Quant data shows AEMD's Return on Capital Employed at 126.88% in Q1 2026, 114.54% in Q4 2025, and 145.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn | 9.30% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 24.24% |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 8.38% |
| 10 | Aethlon Medical | 404,299.61 | 404,299.61 | - | -126.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.88% |
| Dec 31, 2025 | -114.54% |
| Sep 30, 2025 | -145.04% |
| Jun 30, 2025 | -180.93% |
| Mar 31, 2025 | -185.23% |
| Dec 31, 2024 | -166.15% |
| Sep 30, 2024 | -148.41% |
| Jun 30, 2024 | -153.85% |
| Mar 31, 2024 | -168.23% |
| Dec 31, 2023 | -132.49% |
| Sep 30, 2023 | -94.50% |
| Jun 30, 2023 | -83.60% |
| Mar 31, 2023 | -67.56% |
| Dec 31, 2022 | -67.90% |
| Sep 30, 2022 | -71.63% |
| Jun 30, 2022 | -67.52% |
| Mar 31, 2022 | -55.30% |
| Dec 31, 2021 | -40.78% |
| Sep 30, 2021 | -36.89% |
| Jun 30, 2021 | -50.06% |